it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
for the next several days, with relatives keeping a constant vigil, robert held the hand of his wife, who was hooked up to an iv and lethargic from pain medication.
.
.
.
.